Trending Stocks
AI-Detected Trends Before They Happen. Daily short-term research ideas with clear reasoning and a live model portfolio of trending stocks.
Get daily or weekly stock research ideas.
Research content for general circulation. Not individualized advice.
Ideas Cumulative Performance
Currently active model ideas with performance tracking
AI‑linked semiconductor momentum: AXTI has surged ~103% over 21 days and trades ~40% above its 21‑day SMA on strong AI demand for InP, management commentary about sold‑out capacity and early 2026 export‑permit progress. A recent ~$100M equity raise de‑risked near‑term liquidity. With AI/data‑center narratives in focus, the name is positioned for continued short‑term strength while momentum persists.
Turnaround/AI edge play with fresh earnings catalyst: Q4/FY25 showed revenue acceleration, margin improvement and raised guidance, with RPO reportedly up ~55% to $354M and AI/edge messaging catching investor attention. The stock has rallied ~57% over 21 days and trades ~26% above its 21‑day SMA. Despite legal overhang and ongoing losses, the combination of a recent beat, upgraded outlook and strong price action makes FSLY a tactical short‑term momentum candidate.
Short-term fertilizer winner: FY2025 delivered $2.89B adjusted EBITDA, ~$1.8B FCF and strong margins, with tight nitrogen markets and low‑carbon premium initiatives supporting outlook. The stock has rallied ~40% in 21 days and trades ~24% above its 21‑day SMA, reflecting strong momentum as oil/geopolitical risks support fertilizer pricing. Near‑term upside remains on momentum and sector tailwinds, with buybacks and dividend underpinning demand.
Strong near‑term setup: large capital return (up to $2B buyback and $1.5B ASR started 2026-03-09), two positive Phase 3 readouts in March (ralinepag ADVANCE OUTCOMES 2026-03-02 and nebulized Tyvaso TETON‑2 NEJM IPF data 2026-03-11), record FY2025 revenue and >40% net margin, plus ~+13.5% price move into mid‑March. Combination of active repurchases, de‑risked pipeline and technical breakout supports continued upside over the next few days, albeit with biotech volatility.
Browse by Sector
Explore stock research ideas organized by industry sectors. Discover companies and investment opportunities across different market segments.
Best Recent Ideas
Top recent model ideas from our AI-powered pipeline with tracked outcomes
Jyong Biotech (MENS) has surged from $7.50 to over $23 post-IPO, showing exceptional short-term strength and clear higher highs/lows. Momentum traders targeting quick gains could capitalize on further follow-through, though underlying liquidity and trial risks remain significant.
USARW exhibits a strong short-term breakout with a 218% surge over 21 trading days well above its 21-day moving average and the upper Bollinger Band, signaling significant momentum. Despite elevated overbought risk, the strong technical strength and sector demand cyclicality make USARW a compelling hot idea for near-term trading gains with cautious risk management.
AeroVironment has outperformed its sector recently and sits on a technical base around $180–195 ahead of a June earnings release that could validate its strong profitability and revenue growth outlook. The BlueHalo merger adds a fresh growth narrative in drone defense, and the risk/reward looks favorable given the stock’s low leverage and positive analyst sentiment.
Sandisk demonstrates powerful Q1 2026 results with 21% sequential revenue growth, strong gross margins, S&P 500 inclusion, and a 70% January price rally, supported by tight NAND supply and AI data center demand, marking it a high-conviction near-term growth pick despite elevated valuation risk.
Model Ideas History
Complete track record of all published ideas with transparent outcomes.
| Date | Close | Ticker | Company | Summary | Status | P/L |
|---|---|---|---|---|---|---|
| Mar 13 | Mar 20 | AXTI | AXT, Inc. | AI‑linked semiconductor momentum: AXTI has surged ~103% over 21 days and trades ~40% above its 21‑day SMA on strong AI demand for InP, management commentary about sold‑out capacity and early 2026 export‑permit progress. A recent ~$100M equity raise de‑risked near‑term liquidity. With AI/data‑center narratives in focus, the name is positioned for continued short‑term strength while momentum persists. | Active | +0.0% |
| Mar 13 | Mar 20 | FSLY | Fastly, Inc. | Turnaround/AI edge play with fresh earnings catalyst: Q4/FY25 showed revenue acceleration, margin improvement and raised guidance, with RPO reportedly up ~55% to $354M and AI/edge messaging catching investor attention. The stock has rallied ~57% over 21 days and trades ~26% above its 21‑day SMA. Despite legal overhang and ongoing losses, the combination of a recent beat, upgraded outlook and strong price action makes FSLY a tactical short‑term momentum candidate. | Active | +0.0% |
| Mar 13 | Mar 20 | CF | CF Industries Holdings, Inc. | Short-term fertilizer winner: FY2025 delivered $2.89B adjusted EBITDA, ~$1.8B FCF and strong margins, with tight nitrogen markets and low‑carbon premium initiatives supporting outlook. The stock has rallied ~40% in 21 days and trades ~24% above its 21‑day SMA, reflecting strong momentum as oil/geopolitical risks support fertilizer pricing. Near‑term upside remains on momentum and sector tailwinds, with buybacks and dividend underpinning demand. | Active | +0.0% |
| Mar 13 | Mar 20 | UTHR | United Therapeutics Corporation | Strong near‑term setup: large capital return (up to $2B buyback and $1.5B ASR started 2026-03-09), two positive Phase 3 readouts in March (ralinepag ADVANCE OUTCOMES 2026-03-02 and nebulized Tyvaso TETON‑2 NEJM IPF data 2026-03-11), record FY2025 revenue and >40% net margin, plus ~+13.5% price move into mid‑March. Combination of active repurchases, de‑risked pipeline and technical breakout supports continued upside over the next few days, albeit with biotech volatility. | Active | +0.0% |
| Mar 13 | Mar 20 | FIGS | FIGS, Inc. | Short-term momentum with fresh catalysts: Q4/FY25 delivered ~33% YoY revenue growth and an EPS beat ($0.10 vs $0.02), sparking a ~45% 21‑day rally and new 52‑week highs. Price still trades ~9% above its 21‑day SMA with a clear uptrend; a break above the 17.12 recent peak would likely trigger further buying as investors digest the beat and improving margin commentary over the coming sessions. | Active | +0.0% |
| Mar 13 | Mar 20 | S | SentinelOne, Inc. | SentinelOne has a credible near‑term upside case: just reported Q4/FY2026 (3/12) with >$1B revenue, 22% YoY growth and first full‑year operating profitability, plus GovRAMP High and AI product momentum. Liquidity (~$1.2B) and a $200M buyback provide support, while the stock is ~5% above its 21‑day SMA with ~7% 21‑day gains. Improving cash flow and recent earnings newsflow can sustain a short‑term up‑leg if guidance holds. | Active | +0.0% |
| Mar 13 | Mar 20 | RCAT | Red Cat Holdings, Inc. | High‑velocity defense/momentum trade: shares are up ~42% over 21 days and ~18% above the 21‑day SMA ahead of a firm catalyst (formal Q4 2025 results after market close on 2026-03-18). Recent contract wins (Asia‑Pacific selection, Futures Initiative partners) and the launch of a 2x leveraged ETF (RCAX, 2026-02-03) amplify flows. The combination of imminent earnings, defense headlines and leverage product can fuel outsized moves in the next few sessions. | Active | +0.0% |
| Mar 13 | Mar 20 | UCO | ProShares - Ultra Bloomberg Crude Oil | Leveraged oil play with explosive momentum: UCO is up ~75% over 21 days and ~39% above its 21‑day SMA, driven by Middle East supply scares and crude spikes above $100. Geopolitical headlines remain the dominant catalyst; as long as tensions persist, the fund's leveraged exposure can continue to produce outsized short‑term gains, though with very high mean‑reversion risk. | Active | +0.0% |
| Mar 13 | Mar 20 | PARR | Par Pacific Holdings, Inc. | Refiner with strong cash and buyback catalysts: 2025 net income $369M, adjusted EBITDA $633M and ~$296M FCF support a new $250M buyback after retiring ~10% of shares in 2025. SAF partnership with Hawaiian/Alaska Airlines and distillate‑heavy exposure benefit from current refining spreads. The stock is up ~30% over 21 days and ~18% above its 21‑day SMA, making it a high‑conviction near‑term momentum play tied to oil and buyback execution. | Active | +0.0% |
| Mar 13 | Mar 20 | NIO | NIO Inc. | Event‑driven EV momentum: NIO posted Q4 adjusted profit, ~18% vehicle margins and strong revenue, and guided to Q1 deliveries of 80–83k with FY2026 volume growth of 40–50%, creating explicit near‑term milestones. The stock is up ~19% over 21 days and ~16% above its 21‑day SMA, suggesting constructive momentum into monthly delivery prints and Shenji chip‑unit investment news over the coming days. | Active | +0.0% |
How It Works
Our proprietary pipeline combines AI-powered analysis with systematic validation. Learn more about our methodology and check out our FAQ for details.
AI Analysis
Our pipeline continuously monitors news, earnings reports, technical indicators, and price action across thousands of stocks.
Multi-Layer Filtering
Ideas pass through multi-agent analysis framework: fundamental and news screening, technical confirmation, and risk assessment.
Publication & Alerts
Validated model ideas are published with clear reasoning. You may opt in to receive publication alerts.
Frequently Asked Questions
Everything you need to know about Trending Stocks.
Important Legal Disclaimer
Not Investment Advice: All content on this platform is provided for informational and educational purposes only. Nothing on this site constitutes investment advice, financial advice, trading advice, or any other sort of advice.
No Guarantees: Past performance is not indicative of future results. All investments carry risk, and you may lose some or all of your capital.
Do Your Own Research: You are solely responsible for your own investment decisions. Always conduct thorough research and consider consulting with a qualified financial advisor.
Data Accuracy: While we strive for accuracy, we make no warranties about the completeness, reliability, or accuracy of information provided.
By using this service, you acknowledge that you have read and agree to our Terms of Service and Privacy Policy.